Clinical Trials Update: Oct. 25, 2010

Opioid-Induced ConstipationFemale Hypoactive Sexual Desire Disorder (HSDD)Gout

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Opioid-Induced Constipation

This study will evaluate an oral medication to treat opioid-induced constipation in people with chronic, non-malignant pain. Candidates must be 18 or older and have taken a narcotic every day for at least one month.

The research site is in Ormond Beach, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/constipation.aspx.

-----

Female Hypoactive Sexual Desire Disorder (HSDD)

This study will evaluate the safety and effectiveness of an investigational medication for hypoactive sexual desire disorder in women. If you qualify, you'll receive study medication, study-related medical exams and lab tests at no cost.

The research site is in Raleigh, N.C.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/sexual_dysfunction.aspx.

-----

Gout

If you qualify for this study of people with early gout symptoms, you will receive study-related medical care and laboratory testing, and may be compensated for time and travel.

The research site is in Las Vegas, Nev.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.

-----

Copyright 2010 ClinicalConnection.com. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com